La via transdermica come alternativa agli oppioidi per os nel dolore oncologico

Clinica Terapeutica

Volumn 149, Issue 4, 1998, Pages 277-280

  Burza, M ^a   Ginobbi, P ^a   Fusco, G ^a   Laurenzi, L ^a   Tirelli, W ^a   Arcuri, E ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cancer pain; Opioid analgesics; Transdermal administration

Indexed keywords

FENTANYL; OPIATE;

ADULT; ANALGESIA; CANCER PAIN; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; MALE; NOCICEPTION; QUALITY OF LIFE; REVIEW; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANALGESICS, OPIOID; FENTANYL; HUMANS; MORPHINE; NEOPLASMS; PAIN, INTRACTABLE; PALLIATIVE CARE;

EID: 0031729102     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Cancer pain relief and palliative care. Geneva, Switzerland, Word Health Organization,1990
2. Duthie DJR, Rowbotham DJ, Wyld R, et al.: Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients. Br J Anaesth 60: 614-18, 1988
3. Varvel JR, Shafer SL, Hwang SS, et al.: Absorption characteristics of transdermally administered fentanyl. Anaesthesiology 70: 928-34, 1989
4. Lehmann KA, Zech D: Transdermal fentanyl: clinical pharmacology. J Pain and Symptom Management 7 (suppl. 3): 58-S16, 1992
5. Downer B, Michael C, Tryba M, et al.: Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 64: 527-34, 1996
6. Portenoy RK, Southam MA, Gupta SK, et al.: Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics. Anaesthesiology 78: 36-43, 1993
7. Fudin J, Toledo Binette C, Kupiax DM, et al.: Quicker dosage adjustment for transdermal fentanyl. Am J Health Syst Pharm 54: 87-8, 1997
8. Expert working group of European Association for Palliative Care: Morphine in cancer pain: modes ofadministration. B M J 312: 823-26, 1996
9. Hamrnack JE, Mailliard LA, Loprinzi CL, et al.: Transdermal fentanyl in the management of cancer pain in ambulatory patients: An Open-Label Pilot Study. 12 (4): 234-40, 1996
10. American Society of Anaesthesiologists Task Force on Pain Management, Cancer Pain Selection: Practice guidelines for cancer pain management. Anaesthesiology 84: 1243-57, 1996
11. Jeal W, Benfield P: Transdermal fentanyl. A review of TTS pharmacological properties and therapeutic efficacy in pain control. Drugs 53 (1): 109-138, 1997
12. Storey P: More on the conversion of Transdermal Fentanyl to Morphine". In: Journal of Pain and Symptom Management. Vol. 10 n.8: 581, 1995
13. th International Congress on Pain Clinic. Atlanta (Georgia), 1994
14. Weismann DE and Haddox D: Opioid pseudoaddiction: an iatrogenic syndrome. Pain 36: 363-366, 1989
15. Janssen Pharmaceutica. Durogesic (Fentanyl Transdermal System): informazioni farmaceutiche.